100 related articles for article (PubMed ID: 9157604)
1. Antithrombin Morioka (Cys 95-Arg): a novel missense mutation causing type I antithrombin deficiency.
Ozawa T; Takikawa Y; Niiya K; Fujiwara T; Suzuki K; Sato S; Sakuragawa N
Thromb Haemost; 1997 Feb; 77(2):403. PubMed ID: 9157604
[No Abstract] [Full Text] [Related]
2. Antithrombin niigata: a novel missense mutation (Thr194-Ile) of the antithrombin gene results in type I deficiency.
Fuse I; Ozawa T; Higuchi W; Aizawa Y
Thromb Haemost; 2000 Dec; 84(6):1126. PubMed ID: 11154130
[No Abstract] [Full Text] [Related]
3. [A novel mutation in antithrombin gene results in hereditary antithrombin deficiency].
Zhang FH; Ding QL; Wu JS; Zhou RF; Wang XF; Xu XC
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):598-601. PubMed ID: 17278425
[TBL] [Abstract][Full Text] [Related]
4. [Type I antithrombin deficiency due to 13389G deletion in antithrombin gene].
Fu Q; Xu X; Ding Q; Hu Y; Wang X; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):588-90. PubMed ID: 12482344
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral hemorrhage associated with a novel antithrombin gene mutation in a neonate.
Baud O; Picard V; Durand P; Duchemin J; Proulle V; Alhenc-Gelas M; Devictor D; Dreyfus M
J Pediatr; 2001 Nov; 139(5):741-3. PubMed ID: 11713457
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of antithrombin deficiency in Belgian and Dutch families.
Jochmans K; Lissens W; Seneca S; Capel P; Chatelain B; Meeus P; Osselaer JC; Peerlinck K; Seghers J; Slacmeulder M; Stibbe J; van de Loo J; Vermylen J; Liebaers I; De Waele M
Thromb Haemost; 1998 Sep; 80(3):376-81. PubMed ID: 9759613
[TBL] [Abstract][Full Text] [Related]
7. [Type I hereditary antithrombin deficiency due to C2757T heterozygotic mutation in antithrombin gene].
Zhou RF; Dai Q; Fu QH; Wang WB; Xue S; Ding QL; Hu YQ; Wang XF; Wang HL
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1640-2. PubMed ID: 16185535
[No Abstract] [Full Text] [Related]
8. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.
Beauchamp NJ; Pike RN; Daly M; Butler L; Makris M; Dafforn TR; Zhou A; Fitton HL; Preston FE; Peake IR; Carrell RW
Blood; 1998 Oct; 92(8):2696-706. PubMed ID: 9763552
[TBL] [Abstract][Full Text] [Related]
9. Intracellular accumulation of antithrombin Morioka (C95R), a novel mutation causing type I antithrombin deficiency.
Tanaka Y; Ueda K; Ozawa T; Sakuragawa N; Yokota S; Sato R; Okamura S; Morita M; Imanaka T
J Biol Chem; 2002 Dec; 277(52):51058-67. PubMed ID: 12399451
[TBL] [Abstract][Full Text] [Related]
10. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis.
Chowdhury V; Lane DA; Mille B; Auberger K; Gandenberger-Bachem S; Pabinger I; Olds RJ; Thein SL
Thromb Haemost; 1994 Aug; 72(2):198-202. PubMed ID: 7831651
[TBL] [Abstract][Full Text] [Related]
11. Identification of the novel signal peptide mutation, antithrombin-Siriraj causes type-I antithrombin deficiency in thai patients.
Chinthammitr Y; Chinchang W; Ruchutrakool T; Viprakasit V
Thromb Haemost; 2005 Sep; 94(3):678-9. PubMed ID: 16268490
[No Abstract] [Full Text] [Related]
12. Characterization of two novel mutations of the antithrombin gene observed in Japanese thrombophilic patients.
Kurihara M; Watanabe K; Inoue S; Wada Y; Ono M; Wakiyama M; Iida H; Kinoshita S; Hamasaki N
Thromb Res; 2005; 115(5):351-8. PubMed ID: 15733967
[TBL] [Abstract][Full Text] [Related]
13. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.
Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I
Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316
[TBL] [Abstract][Full Text] [Related]
14. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of antithrombin deficiency in two Chinese families. One novel and one recurrent point mutation in the antithrombin gene causing venous thrombosis.
Zhou RF; Fu QH; Wang WB; Xie S; Dai J; Ding QL; Wang XF; Wang HL; Wang ZY
Thromb Haemost; 2005 Dec; 94(6):1172-6. PubMed ID: 16411389
[TBL] [Abstract][Full Text] [Related]
16. Mutation study of antithrombin: the roles of disulfide bonds in intracellular accumulation and formation of russell body-like structures.
Tanaka Y; Ueda K; Ozawa T; Kitajima I; Okamura S; Morita M; Yokota S; Imanaka T
J Biochem; 2005 Mar; 137(3):273-85. PubMed ID: 15809328
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
[TBL] [Abstract][Full Text] [Related]
18. Novel missense mutation resulting in the substitution of tyrosine by cysteine at codon 597 of the type X collagen gene associated with Schmid metaphyseal chondrodysplasia.
Sawai H; Ida A; Nakata Y; Koyama K
J Hum Genet; 1998; 43(4):259-61. PubMed ID: 9852679
[TBL] [Abstract][Full Text] [Related]
19. A novel and de novo spontaneous point mutation (Glu271STOP) of the antithrombin gene results in a type I deficiency and thrombophilia.
Tarantino MD; Curtis SM; Johnson GS; Waye JS; Blajchman MA
Am J Hematol; 1999 Feb; 60(2):126-9. PubMed ID: 9929104
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding.
Borg JY; Brennan SO; Carrell RW; George P; Perry DJ; Shaw J
FEBS Lett; 1990 Jun; 266(1-2):163-6. PubMed ID: 2365065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
